Theory of combinant expression vector of survivin antisense RNA and HSPT0 for the therapy of bladder cancer
10.3760/cma.j.issn.1673-4203.2012.05.019
- VernacularTitle:Survivin反义RNA与HSP70构建双基因表达载体治疗膀胱癌的理论基础
- Author:
Hailin TAN
;
Guowei SHI
- Publication Type:Journal Article
- Keywords:
Survivin;
HSP70;
Bladder carcinoma;
Double genes expression vector
- From:
International Journal of Surgery
2012;39(5):349-353
- CountryChina
- Language:Chinese
-
Abstract:
Carcinoma of urinary bladder is one of the most common tumor.As life rhythm speeding up and lifestyle changing,bladder cancer incident increases year after year.Previous major treatment methods for the disease are open surgery and TURBT,but these therapies can not overcome the characteristics of its recurrence.Since the 21st century along with the rapid development of molecular biology technology,the discovery of Survivin gene,new knowledge about HSP molecules in tumor immunology and the progress of the technique called RNA interference,open up a whole new field for early diagnosis and treatment of bladder carcinoma.Discussing the role of Survivin gene in the development of tumor,survivin antisense RNA' s efficacy and the role of HSP70 in the cancer immunity,the review aims at exploring the possibility of the double gene expression vector constructed by Survivin antisense RNA gene and HSP70 gene for bladder carcinoma therapy.